tradingkey.logo

United-Guardian Inc

UG
查看詳細走勢圖
6.090USD
+0.030+0.50%
收盤 12/19, 16:00美東報價延遲15分鐘
27.98M總市值
14.28本益比TTM

United-Guardian Inc

6.090
+0.030+0.50%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.50%

5天

+1.00%

1月

+5.00%

6月

-25.55%

今年開始到現在

-36.30%

1年

-37.09%

查看詳細走勢圖

TradingKey United-Guardian Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

United-Guardian Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在藥品行業排名107/158位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

United-Guardian Inc評分

相關信息

行業排名
107 / 158
全市場排名
301 / 4582
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

United-Guardian Inc亮點

亮點風險
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
業績增長期
公司處於發展階段,最新年度總收入12.18M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入12.18M美元
高分紅
公司屬於高分紅公司,最新股息支付率84.79%
穩定分紅
公司5年內持續分紅,最新股息支付率84.79%
估值合理
公司最新PE估值14.28,處於3年歷史合理位
機構減倉
最新機構持股1.05M股,環比減少4.12%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉184.76K股

United-Guardian Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

United-Guardian Inc簡介

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
公司代碼UG
公司United-Guardian Inc
CEO
網址https://u-g.com/

常見問題

United-Guardian Inc(UG)的當前股價是多少?

United-Guardian Inc(UG)的當前股價是 6.090。

United-Guardian Inc 的股票代碼是什麼?

United-Guardian Inc的股票代碼是UG。

United-Guardian Inc股票的52週最高點是多少?

United-Guardian Inc股票的52週最高點是11.980。

United-Guardian Inc股票的52週最低點是多少?

United-Guardian Inc股票的52週最低點是5.575。

United-Guardian Inc的市值是多少?

United-Guardian Inc的市值是27.98M。

United-Guardian Inc的淨利潤是多少?

United-Guardian Inc的淨利潤為3.25M。

現在United-Guardian Inc(UG)的股票是買入、持有還是賣出?

根據分析師評級,United-Guardian Inc(UG)的總體評級為--,目標價格為--。

United-Guardian Inc(UG)股票的每股收益(EPS TTM)是多少

United-Guardian Inc(UG)股票的每股收益(EPS TTM)是0.427。
KeyAI